Cargando…

Effects of Pre-conditioning Dose on the Immune Kinetics and Cytokine Production in the Leukocytes Infiltrating GVHD Tissues after MHC-matched Transplantation

BACKGROUND: Graft-versus-host disease (GVHD) is a huddle for success of hematopoietic stem cell transplantation. In this study, effects of irradiation dose on immune kinetics of GVHD were investigated using B6 → BALB.B system, a mouse model for GVHD after MHC-matched allogeneic transplantation. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Jung Hwa, Yoon, Hyewon, Min, Chang-Ki, Choi, Eun Young
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072677/ https://www.ncbi.nlm.nih.gov/pubmed/21494376 http://dx.doi.org/10.4110/in.2011.11.1.68

Ejemplares similares

The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice
Publicado: (1996)

Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation
por: Chen, Xinhua, et al.
Publicado: (2016)

Erratum to: Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation
por: Chen, Xinhua, et al.
Publicado: (2017)

Targeting Cytokines in GVHD Therapy
por: Kumar, Sandeep, et al.
Publicado: (2017)

Impact of Anti-T-lymphocyte globulin dosing on GVHD and Immune reconstitution in matched unrelated myeloablative peripheral blood stem cell transplantation
por: Massoud, Radwan, et al.
Publicado: (2022)

MHC Haplotype Matching for Unrelated Hematopoietic Cell Transplantation
por: Petersdorf, Effie W, et al.
Publicado: (2007)

Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022)

Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies
por: Dou, Liping, et al.
Publicado: (2019)

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation
por: Ueda Oshima, Masumi, et al.
Publicado: (2023)

Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation
por: Lorentino, Francesca, et al.
Publicado: (2022)

Successful Transplantation of Retinal Pigment Epithelial Cells from MHC Homozygote iPSCs in MHC-Matched Models
por: Sugita, Sunao, et al.
Publicado: (2016)

ER stress: an emerging regulator in GVHD development
por: Choi, Hee-Jin, et al.
Publicado: (2023)

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
por: Shokouhi, Shabnam, et al.
Publicado: (2015)

HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia
por: Zi-Min, Sun, et al.
Publicado: (2010)

Dynamic changes in serum cytokine levels and their clinical significance in predicting acute GVHD
por: Zhang, Chunyan, et al.
Publicado: (2017)

Donor bone marrow–derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice
por: Adams, Rachael C., et al.
Publicado: (2022)

Chronic GVHD: predictive factor for rhinosinusitis in bone marrow transplantation
por: Ortiz, Erica, et al.
Publicado: (2015)

Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHD
por: Kostareva, Irina, et al.
Publicado: (2022)

P1329: POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) VERSUS ANTITHYMOCYTE GLOBULIN (ATG) AS GVHD PROPHYLAXIS FOR MATCHED UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.
por: Dachy, F., et al.
Publicado: (2022)

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
por: Wang, Yu, et al.
Publicado: (2019)

Evaluation of Cyclosporine Pharmacokinetic, Monitoring, and Dosing Parameters for GVHD Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Tafazoli, Ali, et al.
Publicado: (2019)

Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy
por: Nawas, Mariam T., et al.
Publicado: (2023)

Differential MHC class I expression in distinct leukocyte subsets
por: Greene, Justin M, et al.
Publicado: (2011)

Leukocyte infiltration in experimental stroke
por: Grønberg, Nina Vindegaard, et al.
Publicado: (2013)

More evidence for low-dose IL-2 for chronic GVHD in children
por: Levine, John E.
Publicado: (2023)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD
por: Shin, Ok S., et al.
Publicado: (2011)

Intestinal aGVHD and infection after hematopoietic stem cell transplantation
por: Hou, Cai-yan, et al.
Publicado: (2013)

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation
por: Faridi, Rehan Mujeeb, et al.
Publicado: (2016)

Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes
por: Su, Min, et al.
Publicado: (2019)

Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
por: Szyska, Martin, et al.
Publicado: (2016)

GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models
por: Hess, Nicholas J., et al.
Publicado: (2021)

Novel insights into GVHD and immune reconstitution after allogeneic hematopoietic cell transplantation
por: Teshima, Takanori, et al.
Publicado: (2023)

Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide
por: Kanakry, Christopher G., et al.
Publicado: (2017)

Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis
por: Roy, Denis Claude, et al.
Publicado: (2019)

Inflammasome effects in GvHD
por: Koehn, Brent H., et al.
Publicado: (2015)

Regulatory T Cells in GVHD Therapy
por: Guo, Wen-wen, et al.
Publicado: (2021)

Milestones in acute GVHD pathophysiology
por: Socie, Gerard, et al.
Publicado: (2022)

Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation
por: Toubai, Tomomi, et al.
Publicado: (2015)

Hidden genomic MHC disparity between HLA-matched sibling pairs in hematopoietic stem cell transplantation
por: Koskela, Satu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r48fa3v3l2punfsjfcss0fkrvd